Drugmaker Wockhardt has been asked by authorities in Himachal Pradesh to stop selling three drugs, the company said, without giving reasons.
In a statement to the stock exchange, the company said the HP drug controller has suspended the manufacture, sale or distribution of fixed dose combination drugs – Dicyclomine Hydrochloride IP 10mg (for irritable bowel syndrome), Tramadol Hydrochloride (for pain) IP 50mg and Acetamenophen IP 325mg (for pain and fever).
Wockhardt said it would file an appeal before the State Government to get the suspension revoked. Business Line
New Delhi, May 17, 2024: In response to the growing need for specialized pediatric care,…
Achieves significant advancement in Cancer Treatment to Enhance Quality of Life As per the National…
-An 11-year-old boy from Yemen and a 34-year-old man from Bengaluru, both suffered from end-stage…
Mumbai, 14th May 2024 – As part of its dedication to exceptional patient care, American Oncology…
Mumbai, May 11, 2024: In a landmark move for Indian healthcare, the introduction of Second…
Bengaluru, May 08, 2024: Cancer remains the illness most feared across the globe. But to combat…